A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
Clinical trial NCT01076699 · SUSPENDED
Trial details
- NCT number
- NCT01076699
- Sponsor
- Revogenex, Inc.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-12-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.